Literature DB >> 19492115

Pd-catalyzed Heck reaction for the synthesis of isomeric metallo tetravinylsulfo phthalocyanines and their photosensitizing properties.

Hasrat Ali1, Nicole Cauchon, Johan E van Lier.   

Abstract

Tetrasulfonated zinc phthalocyanine (ZnPcS(4)) is a potent sensitizer for photodynamic therapy of various medical conditions. Depending on its mode of preparation the material consists of mixtures of ortho and meta sulfonated derivatives as well as regioisomers with different photodynamic potency. To study the effect of the site of substitution on biological parameters that contribute to overall photodynamic efficacy, a series of pure ortho- and meta-tetravinylsulfonated metallo phthalocyanines MPc-o/m-(VS)(4) were prepared from the corresponding tetraiodo phthalocyanines using the palladium-catalyzed cross-coupling reaction (Heck reaction). Compared to the tetrasulfonated phthalocyanines, the tetravinylsulfonated derivatives are more hydrophobic and their Q-band absorption maxima are red-shifted. While their in vitro phototoxicity is in the same range as the mixed isomeric sulfonated derivatives, ortho-substituted MPc-o-(VS)(4) are more photocytotoxic as compared to their corresponding meta analogs. Although the central metal ion and site of substitution affect aggregation, the tendency to aggregate did not correlate with photodynamic potency nor did overall cell uptake. Instead, intracellular localization at both mitochondrial and lysosomal membranes appears to be the major factor explaining the augmented activity of the ortho substituted derivatives.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19492115     DOI: 10.1039/b902530h

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  1 in total

1.  Perinatal Arterial Ischemic Stroke Is Associated to Materno-Fetal Immune Activation and Intracranial Arteritis.

Authors:  Clémence Guiraut; Nicole Cauchon; Martin Lepage; Guillaume Sébire
Journal:  Int J Mol Sci       Date:  2016-11-25       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.